A joint assessment is a structured information for rapid or full/comprehensive HTAs which is the output of joint production in which 2 or more countries and/or organisations work together to prepare shared products or agreed outcomes (Based on definitions from the HTA Network Strategy (page 24) and the EUnetHTA Recommendations (page 6, footnote 8))
Submission template for Pharmaceuticals and Submission template for Medical Devices
JA2-WP7 EUnetHTA Joint Action 2 (2012-15)
2016 - PDF
The EUnetHTA evidence submission template was developed from an analysis of evidence requirements for reimbursement in Europe. It is a tool that agencies can use to request evidence from companies to support their HTA and reimbursement processes. The tool covers relative effectiveness assessment including a description of the health condition and health technology, as well as clinical effectiveness and safety information. It also includes requests for information about the methodology used to produce the HTA (for example how studies were identified). Versions are available for pharmaceuticals and medical devices.